[go: up one dir, main page]

GR3026075T3 - 5-(1-fluoro-vinyl)-1h-pyrimidine-2,4-dione derivatives useful as antineoplastic agents - Google Patents

5-(1-fluoro-vinyl)-1h-pyrimidine-2,4-dione derivatives useful as antineoplastic agents

Info

Publication number
GR3026075T3
GR3026075T3 GR980400243T GR980400243T GR3026075T3 GR 3026075 T3 GR3026075 T3 GR 3026075T3 GR 980400243 T GR980400243 T GR 980400243T GR 980400243 T GR980400243 T GR 980400243T GR 3026075 T3 GR3026075 T3 GR 3026075T3
Authority
GR
Greece
Prior art keywords
pyrimidine
antineoplastic agents
dione derivatives
fluoro
vinyl
Prior art date
Application number
GR980400243T
Other languages
English (en)
Inventor
James R Mccarthy
Donald P Matthews
Jeffrey S Sabol
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/236,599 external-priority patent/US5512678A/en
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of GR3026075T3 publication Critical patent/GR3026075T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
GR980400243T 1993-09-14 1998-02-04 5-(1-fluoro-vinyl)-1h-pyrimidine-2,4-dione derivatives useful as antineoplastic agents GR3026075T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12140593A 1993-09-14 1993-09-14
US08/236,599 US5512678A (en) 1993-09-14 1994-04-29 5-(1-fluoro-vinyl)-1H-pyrimidine-2,4-dione derivatives useful as antineoplastic agents
PCT/US1994/009502 WO1995007917A1 (en) 1993-09-14 1994-08-23 5-(1-fluoro-vinyl)-1h-pyrimidine-2,4-dione derivatives useful as antineoplastic agents

Publications (1)

Publication Number Publication Date
GR3026075T3 true GR3026075T3 (en) 1998-05-29

Family

ID=26819425

Family Applications (1)

Application Number Title Priority Date Filing Date
GR980400243T GR3026075T3 (en) 1993-09-14 1998-02-04 5-(1-fluoro-vinyl)-1h-pyrimidine-2,4-dione derivatives useful as antineoplastic agents

Country Status (16)

Country Link
EP (1) EP0719271B1 (el)
JP (1) JPH09509137A (el)
CN (1) CN1042429C (el)
AT (1) ATE160571T1 (el)
AU (1) AU690579B2 (el)
CA (1) CA2170608C (el)
DE (1) DE69407056T2 (el)
DK (1) DK0719271T3 (el)
ES (1) ES2111330T3 (el)
FI (1) FI961172L (el)
GR (1) GR3026075T3 (el)
HU (1) HUT73414A (el)
IL (1) IL110919A0 (el)
NO (1) NO306348B1 (el)
NZ (1) NZ273161A (el)
WO (1) WO1995007917A1 (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ330360A (en) * 1997-06-02 1999-03-29 Hoffmann La Roche 5'-deoxy-cytidine derivatives, their manufacture and use as antitumoral agents
EP0882734B1 (en) * 1997-06-02 2009-08-26 F. Hoffmann-La Roche Ag 5'-Deoxy-cytidine derivatives
DE10313035A1 (de) * 2003-03-24 2004-10-07 Resprotect Gmbh Methode zur Verstärkung der apoptotischen Wirkung von Zytostatika ohne Erhöhung toxischer Nebenwirkungen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4383990A (en) * 1980-10-01 1983-05-17 Beecham Group Limited Antiviral agents, their preparation and use
US5116823A (en) * 1990-02-27 1992-05-26 Roger Williams General Hospital Drug combinations containing AZT
FR2659330B1 (fr) * 1990-03-09 1994-02-11 Sapec Sa Composes diastereoisomeres derivant de l'acide tetrahydrofolique, procede de preparation et utilisation dans la synthese de diastereomeres 6s et 6r de folates reduits.

Also Published As

Publication number Publication date
NZ273161A (en) 1997-11-24
CA2170608A1 (en) 1995-03-23
CN1130909A (zh) 1996-09-11
CA2170608C (en) 1999-03-30
DE69407056D1 (en) 1998-01-08
HUT73414A (en) 1996-07-29
NO306348B1 (no) 1999-10-25
NO961027L (no) 1996-03-13
JPH09509137A (ja) 1997-09-16
CN1042429C (zh) 1999-03-10
NO961027D0 (no) 1996-03-13
WO1995007917A1 (en) 1995-03-23
FI961172A0 (fi) 1996-03-13
EP0719271A1 (en) 1996-07-03
HU9600644D0 (en) 1996-05-28
AU7636394A (en) 1995-04-03
IL110919A0 (en) 1994-11-28
AU690579B2 (en) 1998-04-30
ES2111330T3 (es) 1998-03-01
DE69407056T2 (de) 1998-04-09
DK0719271T3 (da) 1997-12-29
FI961172A7 (fi) 1996-03-13
FI961172L (fi) 1996-03-13
ATE160571T1 (de) 1997-12-15
EP0719271B1 (en) 1997-11-26

Similar Documents

Publication Publication Date Title
UA41290C2 (uk) Гетероариламіни, фармацевтична композиція, спосіб інгібування холінестерази у ссавців, спосіб покращення пам'яті
DE69919897D1 (en) 4-oxo-1,4-dihydro-3-chinolincarboxamide als antivirale mittel
AU2910600A (en) Phenyl urea and phenyl thiourea derivatives
HUP9802304A2 (hu) Piridazin-3-on-származékok, intermedierjeik, alkalmazásuk, a vegyületeket hatóanyagként tartalmazó herbicid készítmények
AU7316387A (en) Pyrrole-amidine antitumorals
MX9801129A (es) Agentes farmaceuticos.
CA2396738A1 (en) Thiazole derivatives as active superoxide radical inhibitors
MY129935A (en) Dihydropyridine derivatives useful in antitumor therapy
BG101601A (bg) Фармацевтични пиперазинови производни
ES8707525A1 (es) Un procedimiento para la preparacion de nuevas isoindolinil-alquilpiperazinas
CA2039039A1 (en) Pyrimidine nucleoside derivative and antiviral agent containing the derivative as active ingredient
TR199700354A2 (xx) Karbohidrat t�revleri.
MX9701949A (es) Derivados de distamicina substituidos con bis-(2-haloetil) aminofenilo como agentes antitumorales y antivirales.
IL110919A0 (en) 5-(1-fluoro-vinyl)-1h-pyrimidine-2,4-dione derivatives useful as antineoplastic agents
ES8603809A1 (es) Un procedimiento para preparar un derivado de fluoralilamina
TR199801648T2 (xx) Herbisid olarak pirazol-4-il-hetaroil t�revleri
MX9706014A (es) Derivados de xanteno y acridina y su empleo.
IE800620L (en) Tetrahydrothiophenes
WO1995002603A3 (en) Use of cephem derivatives as anti-metastatic agents
NZ310385A (en) Novel derivatives of swainsonine, processes for their preparation and their use as therapeutic agents
ES8704881A1 (es) Un procedimiento para la preparacion de anilidas de acidos arilaceticos sustituidos.
ATE123025T1 (de) 2-amino-n-(((4-(aminocarbonyl)pyrimidin-2- yl>amino>alkyl>-pyrimidin-4- carbonsäureamidderivate, ihre herstellung und ihre anwendung in der therapeutica.
NZ222321A (en) 1-carbamoyl-2-pyrazoline derivatives and herbicidal compositions
ATE260261T1 (de) Oligobenzimidazolderivate und ihre verwendung als dna-transfektionsmittel
CO4940468A1 (es) Nuevos derivados de naftilpiperacina